Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Deferasirox products are in shortage in Canada (1 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An iron chelator used to remove excess iron from the body, usually caused by repeated blood transfusions.
Products affected
1 / 21
In shortage since
Mar 10, 2026
Reports on file
47
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PMS-DEFERASIROX (TYPE J)
360MG · TABLET · PHARMASCIENCE INC
DIN 02528312 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
SANDOZ DEFERASIROX
250MG · TABLET FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02464462 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-DEFERASIROX (TYPE J)
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02507315 · ended Dec 12, 2025 · Available inventory expires Mar 2026
Resolved
TARO-DEFERASIROX (TYPE J)
360MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02507331 · ended Dec 10, 2025 · Available inventory expires Mar 2026
Resolved
TARO-DEFERASIROX (TYPE J)
180MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02507323 · ended Dec 9, 2025 · Available inventory expires Mar 2026
Resolved
APO-DEFERASIROX
250MG · TABLET FOR SUSPENSION · APOTEX INC
DIN 02461552 · ended May 15, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DEFERASIROX (TYPE J)
90MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489899 · ended Apr 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ DEFERASIROX (TYPE J)
360MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489910 · ended Apr 21, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DEFERASIROX (TYPE J)
180MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489902 · ended Apr 21, 2025 · Demand increase for the drug.
Resolved
APO-DEFERASIROX (TYPE J)
180MG · TABLET · APOTEX INC
DIN 02485273 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-DEFERASIROX
250MG · TABLET FOR SUSPENSION · APOTEX INC
DIN 02461552 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DEFERASIROX (TYPE J)
360MG · TABLET · APOTEX INC
DIN 02485281 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 47 reports. All reports are on file with Health Canada.
What's happening
Deferasirox is currently affected by an active shortage report filed with Health Canada by PHARMASCIENCE INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Deferasirox is classified under “ALL OTHER THERAPEUTIC PRODUCTS” (ATC V03AC).
Recent changes
No changes recorded yet.
Common questions
What is Deferasirox used for?
An iron chelator used to remove excess iron from the body, usually caused by repeated blood transfusions.
When will Deferasirox be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Deferasirox in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.